Membrane Protein Structures and Interactions in the M. tuberculosis Divisome
结核分枝杆菌分裂体中的膜蛋白结构和相互作用
基本信息
- 批准号:8944802
- 负责人:
- 金额:$ 76.44万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-04-20 至 2020-03-31
- 项目状态:已结题
- 来源:
- 关键词:AntibioticsBacillus subtilisBacteriaBindingBinding SitesBiologyBiophysicsC-terminalCell WallCell divisionCell membraneCellsCessation of lifeCommunicationComplexCytoplasmDiseaseDrug TargetingDrug resistance in tuberculosisEnvironmentEscherichia coliExposure toFoundationsGoalsHomologous GeneIndividualIntegral Membrane ProteinJointsKnowledgeLabelLeadLengthLipid BilayersLipidsMagicMembraneMembrane ProteinsMethodologyMicrobiologyMultiple PartnersMycobacterium tuberculosisPeptidoglycanPharmaceutical PreparationsPositioning AttributeProcessProteinsPublicationsRecruitment ActivityResearchSamplingSolutionsStagingStructural ProteinStructureSurfaceTechnologyTherapeuticToxinTransmembrane DomainTuberculosisTwo-Hybrid System TechniquesWaterWorkdaughter cellexperiencefallsfrontierinterestkillingsmeetingsmolecular dynamicsnovelnovel therapeuticspreventprotein complexprotein protein interactionprotein structurepublic health relevanceresearch studyrestraintsolid solutionsolid statesolid state nuclear magnetic resonancestructural biologytooltuberculosis drugstuberculosis treatment
项目摘要
DESCRIPTION (provided by applicant): Relatively little is known about the cell division machinery, or divisome, of Mycobacteria tuberculosis (Mtb), the causative agent of tuberculosis (TB). There have been no new TB drug classes developed since a multidrug 6-month treatment course was introduced in the 1970s. New therapies are desperately needed for TB as the occurrence of multi-drug and extensive drug-resistant TB has increased rapidly in the past decade. The goal of this project is to advance knowledge of the Mtb divisome as potential drug targets and towards this end achieve an understanding of how the divisome proteins interact with each other and hence, how they are recruited to the divisome. Four transmembrane proteins are targeted for structural characterizations, both individually and as complexes. The Specific Aims are: (1) characterize nascent and binding-induced structures of intrinsically disordered regions in the protein targets; (2) determine full-length structures of these proteins i lipid bilayers; (3) determine structures of complexes formed between these membrane proteins and with other divisome proteins and peptidoglycan precursors or fragments. Combining expertise in microbiology and structural biology with membrane protein and computational biophysics, the research will lead to critical knowledge on the activities and interactions of central layers in the divisome. An array of tools will be used, including bacterial two-hybrid assays, solid state and solution NMR, and restrained molecular dynamics. To meet the challenge of characterizing the proteins and protein complexes in a native-like, lipid bilayer environment, new structural methodologies, including a novel type of structural restraints from solid state NMR and a novel use of solid state NMR for conformational characterization of intrinsically disordered regions in membrane proteins, will be developed. This interdisciplinary team, with significant and unique experiences of the individuals and through prior joint publications, is ideally positioned to accomplish the proposed studies. These structural characterizations of the Mtb divisome and their functional implications will generate novel therapeutic opportunities for TB. The technologies developed here will represent the frontier of membrane protein structure biology. 1
描述(由申请人提供):关于结核病(TB)的病原体结核分枝杆菌(Mtb)的细胞分裂机制或分裂体的了解相对较少。自20世纪70年代采用6个月多药疗程以来,没有开发出新的结核病药物类别。在过去十年中,由于多药耐药和广泛耐药结核病的发生率迅速增加,迫切需要新的结核病疗法。该项目的目标是推进Mtb divisome作为潜在药物靶点的知识,并为此实现对divisome蛋白如何相互作用以及它们如何被招募到divisome的理解。四个跨膜蛋白的结构表征,无论是单独的和作为复合物的目标。具体目标是:(1)表征蛋白质靶中固有无序区域的新生和结合诱导的结构;(2)确定脂质双层中这些蛋白质的全长结构;(3)确定这些膜蛋白之间以及与其它分裂体蛋白和肽聚糖前体或片段形成的复合物的结构。将微生物学和结构生物学的专业知识与膜蛋白和计算生物物理学相结合,这项研究将导致对分裂中中心层的活动和相互作用的关键知识。将使用一系列工具,包括细菌双杂交测定,固态和溶液NMR,和限制分子动力学。为了满足的挑战,表征蛋白质和蛋白质复合物在一个天然的,脂质双层环境,新的结构方法,包括一种新的类型的结构限制从固态NMR和一种新的使用固态NMR的固有的膜蛋白质中的无序区域的构象表征,将开发。这个跨学科的团队,具有重要和独特的个人经验,并通过以前的联合出版物,是理想的定位,以完成拟议的研究。结核分枝杆菌分裂体的这些结构特征及其功能意义将产生新的治疗结核病的机会。这里开发的技术将代表膜蛋白结构生物学的前沿。1
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TIMOTHY A CROSS其他文献
TIMOTHY A CROSS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TIMOTHY A CROSS', 18)}}的其他基金
14.1 T magnet with +/-1280 G Field Regulation and Integrated MAS Cryogenic System
14.1 T 磁铁,带 /-1280 G 磁场调节和集成 MAS 低温系统
- 批准号:
8734553 - 财政年份:2014
- 资助金额:
$ 76.44万 - 项目类别:
M tuberculosis Membrane Protein Pharmaceutical Targets
结核分枝杆菌膜蛋白药物靶点
- 批准号:
7917414 - 财政年份:2009
- 资助金额:
$ 76.44万 - 项目类别:
M tuberculosis Membrane Protein Pharmaceutical Targets
结核分枝杆菌膜蛋白药物靶点
- 批准号:
7561796 - 财政年份:2009
- 资助金额:
$ 76.44万 - 项目类别:
M tuberculosis Membrane Protein Pharmaceutical Targets
结核分枝杆菌膜蛋白药物靶点
- 批准号:
8608194 - 财政年份:2009
- 资助金额:
$ 76.44万 - 项目类别:
M tuberculosis Membrane Protein Pharmaceutical Targets
结核分枝杆菌膜蛋白药物靶点
- 批准号:
8519276 - 财政年份:2009
- 资助金额:
$ 76.44万 - 项目类别:
M tuberculosis Membrane Protein Pharmaceutical Targets
结核分枝杆菌膜蛋白药物靶点
- 批准号:
8116483 - 财政年份:2009
- 资助金额:
$ 76.44万 - 项目类别:
相似国自然基金
基于Bacillus subtilis 细胞传感器介导的肠道环境中结直肠癌相关生物标志物的动态检测策略
- 批准号:82372355
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
枯草芽孢杆菌Bacillus subtilis T5高效制备纳米硒及其合成机制研究
- 批准号:n/a
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
CRISPR/CasΦ介导的Bacillus subtilis基因组精简重排进化与生理机制解析
- 批准号:32300064
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于萌发受体GerA的Bacillus subtilis芽孢萌发信号传导机制研究
- 批准号:
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
菌株Bacillus subtilis GW-01跨膜运输β-氯氰菊酯的特性研究
- 批准号:31801644
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
Bacillus subtilis芽孢合成期乙偶姻合成代谢流重排研究
- 批准号:31500065
- 批准年份:2015
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
土壤活性颗粒与信号分子CSF的互作及其对Bacillus subtilis自然转化的影响
- 批准号:41571230
- 批准年份:2015
- 资助金额:80.0 万元
- 项目类别:面上项目
Bacillus subtilis双精氨酸转运系统中信号肽定向识别的分子机制
- 批准号:31400058
- 批准年份:2014
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
基于迭代饱和突变技术的Bacillus subtilis LipA手性识别机制研究
- 批准号:21106064
- 批准年份:2011
- 资助金额:28.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Constitutive oxalate-biodegrading Bacillus subtilis for kidney stones
用于肾结石的组成型草酸盐生物降解枯草芽孢杆菌
- 批准号:
10740242 - 财政年份:2023
- 资助金额:
$ 76.44万 - 项目类别:
Molecular Mechanisms of Y-Family Translesion Polymerase Activity in Bacillus subtilis
枯草芽孢杆菌 Y 家族跨损伤聚合酶活性的分子机制
- 批准号:
10730396 - 财政年份:2023
- 资助金额:
$ 76.44万 - 项目类别:
Mechanisms and regulation of replication, the cell cycle, gene expression, and horizontal gene transfer in prokaryotes, focusing on Bacillus subtilis
原核生物复制、细胞周期、基因表达和水平基因转移的机制和调控,重点关注枯草芽孢杆菌
- 批准号:
10792219 - 财政年份:2023
- 资助金额:
$ 76.44万 - 项目类别:
Chemical Biology of Nitroxyl (HNO) in Bacillus Subtilis
枯草芽孢杆菌中硝酰基 (HNO) 的化学生物学
- 批准号:
10730746 - 财政年份:2023
- 资助金额:
$ 76.44万 - 项目类别:
Mechanisms and regulation of replication, the cell cycle, gene expression, and horizontal gene transfer in prokaryotes, focusing on Bacillus subtilis.
原核生物复制、细胞周期、基因表达和水平基因转移的机制和调控,重点关注枯草芽孢杆菌。
- 批准号:
10552390 - 财政年份:2023
- 资助金额:
$ 76.44万 - 项目类别:
Interrogating laboratory-adapted strains of Bacillus subtilis to elucidate the selective pressures of laboratory conditions on multicellular bacterial behaviors
研究实验室适应的枯草芽孢杆菌菌株,以阐明实验室条件对多细胞细菌行为的选择压力
- 批准号:
10577916 - 财政年份:2023
- 资助金额:
$ 76.44万 - 项目类别:
YloC, a new ribonuclease of Bacillus subtilis
YloC,枯草芽孢杆菌的新型核糖核酸酶
- 批准号:
10736779 - 财政年份:2023
- 资助金额:
$ 76.44万 - 项目类别:
Bacillus Subtilis Chaperone/protease Mechanisms In Metabolic Shutdown
枯草芽孢杆菌伴侣/蛋白酶代谢关闭机制
- 批准号:
BB/X001415/1 - 财政年份:2023
- 资助金额:
$ 76.44万 - 项目类别:
Research Grant
Determination and optimization of Bacillus subtilis traits required for its establishment, persistence and activities on plant roots
枯草芽孢杆菌在植物根部建立、持久性和活性所需性状的确定和优化
- 批准号:
RGPIN-2020-07057 - 财政年份:2022
- 资助金额:
$ 76.44万 - 项目类别:
Discovery Grants Program - Individual
Constitutive oxalate-biodegrading Bacillus subtilis for kidney stones
用于肾结石的组成型草酸盐生物降解枯草芽孢杆菌
- 批准号:
10484663 - 财政年份:2022
- 资助金额:
$ 76.44万 - 项目类别: